Freiburg, Germany

Roland Rauchfuss

This inventor holds 1 USPTO granted patent. Top assignee: Goedecke Aktiengesellschaft. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Roland Rauchfuss. Retrieved from https://idiyas.com/inventor/roland-rauchfuss

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 1.0

ph-index = 1

Forward Citations = 47(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Roland Rauchfuss

Introduction

Roland Rauchfuss is a notable inventor based in Freiburg, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions. His work has led to advancements that benefit both the industry and patients alike.

Latest Patents

Rauchfuss holds a patent for a "Process for the production of retarded pharmaceutical compositions." This invention showcases his expertise in creating formulations that enhance the efficacy and delivery of medications. He has 1 patent to his name, reflecting his commitment to innovation in the pharmaceutical sector.

Career Highlights

Throughout his career, Roland Rauchfuss has been associated with Goedecke Aktiengesellschaft, a company known for its contributions to the pharmaceutical industry. His role at the company has allowed him to apply his inventive skills and collaborate with other professionals in the field.

Collaborations

[This section has been skipped due to space constraints.]

Conclusion

Roland Rauchfuss exemplifies the spirit of innovation in the pharmaceutical industry through his patent and work at Goedecke Aktiengesellschaft. His contributions continue to influence the development of effective pharmaceutical compositions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…